Understanding controlled trials. What are pragmatic trials?

British Medical Journal

Volumn 316, Issue 7127, 1998, Pages 285-289

  Roland, Martin ^a   Torgerson, David J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; BENZODIAZEPINE; BRONCHODILATING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; LORAZEPAM; MORPHINE; OPIATE;

ANALGESIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENERAL ASPECTS OF DISEASE; HEART DISEASE; HUMAN; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PAIN; PALLIATIVE THERAPY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SHORT SURVEY; SUBLINGUAL DRUG ADMINISTRATION;

EID: 0032561943     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (2)

1. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. J Chron Dis 1967;20:637-48.
2. Riggs BL, Hodgson SF, O'Fallon M, Chao EY, Wahner HW, Muhs JM, et al. Effect of fluoride treatment on the fracture rate in post-menopausal women with osteoporosis. N Engl J Med 1990;322:802-9.